Dyadic adds three more to strengthen Scientific Advisory Board

14 Oct '05

3 min read

Biological products developer Dyadic International Inc announced changes to its Scientific Advisory Board (SAB).

Joining Dyadic's SAB are Arnold Demain, Ph.D., Professor of Industrial Microbiology, Emeritus, Massachusetts Institute of Technology, Carlos Barbas, III, Ph.D., Kellogg Professor and Chair of Molecular Biology and Chemistry at The Scripps Research Institute (TSRI), and Joseph Villafranca, Ph.D., Executive Vice President, Pharmaceutical Development and Operations, Neose Technologies Inc.

Leaving Dyadic's SAB are Edward McGuire, Ph.D., former Vice President of Research & Development, Neose Technologies Inc, and Michael Koslowski, Ph.D, Chief Scientist, Kreido Laboratories.

"The new SAB members fit exceptionally well into Dyadic's strategy for the future and will help guide the company to select the best opportunities among the numerous fields where Dyadic's technologies can be applied," commented Mark Emalfarb, Dyadic's President and CEO.

Bios for Drs. Demain, Barbas and Villafranca follow below. For complete bios of all of Dyadic's SAB's current members, please visit Dyadic's website at http://www.dyadic-group.com.

Arnold Demain, Ph.D.
Dr. Demain has been in the forefront of industrial microbiology and biotechnology for over four decades and has been involved in the research and commercialization of a number of fermentation based pharmaceutical processes. He is currently a Fellow at Drew University's Charles A. Dana Institute for Scientists Emeriti. Previously, Dr. Demain was at the Massachusetts Institute of Technology (MIT) for 32 years, where he most recently served as Professor of Industrial Microbiology in the Department of Biology.

More Dyadic International Inc News... More Information Technology News - United States Of America...